Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
about
Reduced Risk of Parkinson's Disease in Users of Calcium Channel Blockers: A Meta-AnalysisDiabetes and risk of Parkinson's disease: a systematic review and meta-analysisMetabolic syndrome: an important risk factor for Parkinson's diseaseMeeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studiesEnhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.Quantification of diabetes comorbidity risks across life using nation-wide big claims dataReply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?A Life-Long Approach to Physical Activity for Brain Health.Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US womenSerum cholesterol and the progression of Parkinson's disease: results from DATATOP.An exploratory study on CLU, CR1 and PICALM and Parkinson diseaseStatin use and Parkinson's disease in Denmark.Total cholesterol and the risk of Parkinson's disease: a review for some new findings.Ubiquitin C-terminal hydrolase L1 is required for pancreatic beta cell survival and function in lipotoxic conditions.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.Insulin resistance and gray matter volume in neurodegenerative disease.Diabetes and risk of Parkinson's disease.β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.Vascular risk factors and clinical progression in spinocerebellar ataxiasDiabetes and the risk of developing Parkinson's disease in Denmark.Apolipoprotein E genotypes and the risk of Parkinson diseaseEffects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged ratsRisk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.Statin Use and the Risk of Parkinson's Disease: An Updated Meta-AnalysisMetabolic markers or conditions preceding Parkinson's disease: a case-control study.Prospective study of plasma urate and risk of Parkinson disease in men and women.Obesity, diabetes, and risk of Parkinson's disease.Diabetes in patients with idiopathic Parkinson's disease.Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.Prospective cohort study of type 2 diabetes and the risk of Parkinson's diseaseHigher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's DiseaseEffects of centrally acting ACE inhibitors on the rate of cognitive decline in dementiaEtiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic FeaturesDietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study.Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients.Dietary fats, cholesterol and iron as risk factors for Parkinson's disease.Novel cerebrovascular pathology in mice fed a high cholesterol diet.Lipid dysfunction and pathogenesis of multiple system atrophy.
P2860
Q26783271-E4EB39C5-6147-4543-B475-DAC5CD8B5CFEQ26849796-720F8F56-7292-4E48-BFFF-98B64F937213Q27023711-44B8A1D4-6861-47B3-9ED0-2AE18DD69F7AQ28387116-C7C2B843-AEC5-4AAB-AC32-65F2EF1B8F19Q28538916-2DAE1C7E-57AE-4E32-A58F-0F5A84D50F96Q30719731-3A033B5C-7D6A-48A8-8ECF-FA460FABC99CQ30927990-D062E9F2-6788-49EC-B968-D556BDD5134BQ33348468-A6923BD3-58CB-4896-97AB-E40D42EE3069Q33715695-9F0190AF-9C51-4C61-83F6-FA680AF4275AQ33848992-26FD5A37-5301-4268-A7EF-A565E468A78AQ33996828-2F4907AA-6BC3-4C85-BD56-ABE992828BDAQ34017691-519AC6BB-EC29-4C7F-986C-21D0B48F2578Q34020626-F9C6CADE-0BEB-4B94-A44F-914C70976563Q34212035-0DC0C1BF-5EA6-41BC-9496-14AB4F61380AQ34228778-24A65ECB-516F-49D2-9EE0-C0CAF8D78375Q34243731-5F119E82-CFF6-4485-9AFD-F63B2E578F52Q34307833-7FDDAFB6-EC9F-4F58-9A45-1B7AC448DF76Q34412464-77ACC460-6F5C-491F-9A98-798615A37993Q34718429-4A846DCC-BCA4-444E-A878-FD8516BCFB45Q35026210-BA5A79ED-5DEB-4BF1-A293-7D6E2FF9B26FQ35040744-6D3B9ADB-B543-4B56-91D5-19A102548069Q35043736-36FAF3B3-BF73-4ECD-A8EB-77C626E37053Q35211228-8E66BA71-7D1B-40F8-BF81-45F8B2DF11FEQ35435092-8D61444B-341F-4AC6-9163-93903A2E9580Q35898211-E25E2456-D2A8-468E-B2D6-765FA40AC450Q35971467-D68C8A8A-FB93-40EA-880B-0237DFB9D05CQ36516892-7BBCD320-2FB1-451E-8BEB-289024179787Q36580376-D402D93E-669A-4BF7-AD3B-52989228F49DQ36769272-BF6A9DF0-C8AD-41B8-A97A-AA1F7BDAE10FQ36842047-D6FBCCB8-241A-4AFB-BAEF-9A3163459877Q36891855-89780E64-F5E7-4F59-B7F8-50C461EA4104Q36906241-3B5A0B21-BCEA-4D24-93D0-B15C559CCC61Q36983489-03442945-E6BF-47E3-9866-F5E9F0B7BA1DQ36989228-3ECB1594-8DB6-47EE-8D56-E977C2457C91Q36995708-3B2AC62A-C16B-4EE2-9952-AD74A48588F3Q37058206-D774BD2A-487F-4B8E-BE02-1898D82DC1C3Q37267160-E648C439-960D-4DF7-87E4-1070CC781BF3Q37362433-657B7B94-AE46-4868-A757-3640A8A310A4Q37414216-5392824E-3B40-4F76-9AEB-E3BE93D4B3D2Q37580065-3BBED252-281F-4896-9FAD-7FDFEF82A363
P2860
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@ast
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@en
type
label
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@ast
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@en
prefLabel
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@ast
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@en
P2860
P50
P1433
P1476
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
@en
P2093
Kelly Claire Simon
P2860
P304
P356
10.1212/01.WNL.0000271883.45010.8A
P407
P577
2007-08-29T00:00:00Z